Descriptive Epidemiological Study and Death Risk Factors for Coronavirus Disease 2019 (Covid-19) in Riau Province
DOI:
https://doi.org/10.25311/keskom.Vol9.Iss1.1429Keywords:
Covid-19, comorbidity, risk of deathAbstract
COVID-19 is a global health problem including in Indonesia. Various interventions and policies have been implemented in controlling the Covid-19 pandemic, but the incident rate and Case Fatality Rate (CFR) from Covid-19 have continued to increase. Even the number of Covid -19 cases in Riau Province ranks 8th out of 34 provinces in Indonesia (RI Ministry of Health, 2021b). Research objectives Describe epidemiological characteristics and analyze risk factors for Covid-19 death in Riau Province. This research is an observational study using the NAR epidemiological investigation (PE) big database for the time period 5 April 2020- 5 April 2021. The study design is a descriptive cross-sectional study and an analytical cross-sectional study. all confirmed cases reported in the PE NAR recapitulation of Riau Province in the reporting period 5 April 2020-5 April 2021. The sample in this study was the total population (saturated sample). Univariate and bivariate analysis with chi-square test using software and computerization. The results of this study showed that there was a relationship between comorbidities (heart P value 0.001; COPD, pValue 0.0001; Kidney P Value 0.001 and Hypertension Pvalule 0.001) with Covid-19 mortality. So Covid patients who have comorbidities must be treated appropriately and quickly. For people who have comorbidities and must comply with health protocols.
Downloads
References
Kementerian Kesehatan Republik Indonesia. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Germas (2020).
World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/ (2021).
Dinkes Provinsi Riau. Riau Tanggap COVID-19. https://corona.riau.go.id (2021).
Kemenkes RI. Peta Sebaran COVID-19. https://covid19.go.id/ (2021).
Lapau, B. Prinsip dan Metode Surveilens Epidemiologi. (Yayasan Pustaka Obor Indonesia, 2018).
Rozaliyani, A. et al. Factors Associated with Death in COVID-19 Patients in Jakarta, Indonesia: An Epidemiological Study. Acta Med. Indones. 52, 246–254 (2020).
Gugus Tugas Percepatan Penanganan COVID-19. Peta Sebaran COVID-19 di Indonesia. https://covid19.go.id/peta-sebaran (2020).
Elviani, R., Anwar, C. & Januar Sitorus, R. Gambaran Usia Pada Kejadian Covid-19. JAMBI Med. J. ‘Jurnal Kedokt. dan Kesehatan’ 9, 204–209 (2021).
Kalantari, H., Tabrizi, A. H. H. & Foroohi, F. Determination of COVID-19 prevalence with regards to age range of patients referring to the hospitals located in western Tehran, Iran. Gene Reports 21, (2020).
Stewart C. Daily new coronavirus (COVID-19) cases in Italy since February 2020 (as of December 3, 2020), by date of report. https://www.statista.com/statistics/1101690/coronavirus-new-cases-development-italy/%0A (2020).
Mayestika, P. & Hasmira, M. H. Artikel Penelitian. J. Perspekt. 4, 519 (2021).
Gemmati, D. et al. COVID-19 and individual genetic susceptibility/receptivity: Role of ACE1/ACE2 genes, immunity, inflammation and coagulation. might the double x-chromosome in females be protective against SARS-COV-2 compared to the single x-chromosome in males? Int. J. Mol. Sci. 21, 1–23 (2020).
Selaras, H. M., Yusuff, A. A., Roheman, R. & Yusuf, H. Hubungan Kepatuhan Protokol Kesehatan Dengan Kejadian Covid-19 Pada Petugas Kesehatan Puskesmas Luragung Di Kabupaten Kuningan. J. Kesehat. Mahardika 8, 80–85 (2022).
Krisdiana, H. et al. Hubungan Beban Kerja Tenaga Kesehatan dengan Kelelahan Kerja di Puskesmas Kecamatan Sukmajaya Kota Depok Selama Pandemi Relationship Workload of Medical Workforce with Work Fatigue in Sukmajaya Sub-District Health Center Depok City at Pandemic. 136–147 (2020).
Muryanto, I. Kematian Akibat Covid-19 di Kabupaten Rokan Hulu: Studi Epidemiologi Deskriptif. J. Kesehat. Komunitas 7, 381–386 (2021).
Drew, C. & Adisasmita, A. C. Gejala dan komorbid yang memengaruhi mortalitas pasien positif COVID-19 di Jakarta Timur, Maret-September 2020. Tarumanagara Med. J. 3, 274–283 (2021).
Zhou, Y. et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int. J. Infect. Dis. 99, 47–56 (2020).
Alkautsar, A. Hubungan Penyakit Komorbid Dengan Tingkat Keparahan Pasien Covid-19. J. Med. Hutama 03, 1488–1494 (2021).
Guan, W. et al. Original article. (2020).
Badawi, A. & Ryoo, S. G. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int. J. Infect. Dis. 49, 129–133 (2016).
Nelwan, J. E. Kejadian Corona Virus Disease 2019 berdasarkan Kepadatan Penduduk dan Ketinggian Tempat per Wilayah Kecamatan. J. Public Heal. Community Med. 1, 32–45 (2020).
Saputra, Y. E., Prahasanti, K., Laitupa, A. A. & Irawati, D. N. Gambaran Faktor Risiko Lanjut Usia Terhadap Kematian Pasien COVID-19. J. Pandu Husada 2, 114 (2021).
Rusmini, H. pISSN:2355-7583 | eISSN:2549-4864 http://ejurnalmalahayati.ac.id/index.php/kesehatan. 9, 861–874 (2022).
Masdalena. FAKTOR RISIKO KOMORBID PADA KEMATIAN COVID-19 DI RUMAH SAKIT X PEKANBARU TAHUN 2021. 3, 105–117 (2021).
Whiteman, E. The effects of hypertension as an existing comorbidity on mortality rate in patients with COVID-19 A systematic review and meta-analysis. Kaos GL Derg. 8, 147–154 (2020).
Ortiz, A. et al. Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-edta. Nephrol. Dial. Transplant. 36, 87–94 (2021).
Karya, K. W. S., Suwidnya, I. M. & Wijaya, B. S. Hubungan penyakit komorbiditas terhadap derajat klinis COVID-19. Intisari Sains Medis 12, 708 (2021).
Downloads
Submitted
Accepted
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Jurnal Kesehatan Komunitas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright @2017. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted non-commercial used, distribution and reproduction in any medium
